Combined immune score predicts the prognosis of newly diagnosed multiple myeloma patients in the bortezomib-based therapy era

To investigate the effect of a combined immune score including the lymphocyte-to-monocyte ratio (LMR) and uninvolved immunoglobulin (u-Ig) levels on the prognosis of newly diagnosed multiple myeloma (NDMM) patients treated with bortezomib. Clinical data of 201 NDMM patients were retrospectively anal...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Min, Guo, Honggang, Liu, Siwei, Xu, Fangfang, Zhang, Yin, Shi, Jie, Xu, Zhiwei, Chen, Yuqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4800
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519192/
https://www.ncbi.nlm.nih.gov/pubmed/34731142
http://dx.doi.org/10.1097/MD.0000000000027521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8519192/
https://www.ncbi.nlm.nih.gov/pubmed/34731142
http://dx.doi.org/10.1097/MD.0000000000027521

Ejemplares similares